Motilegaz Forte, 120 mg capsules 20 pcs

Pharmacotherapeutic group: other medicinal products for the treatment of functional disorders of the gastrointestinal tract.

ATX code: A03AX13. Pharmacological properties

Pharmacodynamics

Simethicone is a chemically inert methylsiloxane polymer containing about 5% silicon dioxide.

Simethicone has foaming and anti-foaming properties and significantly reduces the surface tension of purified water and model surfactant solutions. The results of foaming experiments demonstrated complete foam destruction within 3-6 seconds when adding a liquid suspension of simethicone at a concentration of 0.1 mg/ml. Below this threshold, complete foam destruction does not occur. As a defoamer simethicone is also effective at a concentration of 0.1 mg/ml. This effect lasts for more than 24 hours.

The mechanism of action is based on the distribution of the silicone liquid over the surface of the foam film as well as on a local change in surface tension in the contact area. This causes rapid drainage of the liquid, which helps to break up the film, with the consequent possibility for the released gas to be absorbed or expelled naturally.

Pharmacokinetics

Simethicone is a chemically inert substance that has no physiological activity and is not absorbed, passed through the digestive tract and eliminated as is.

Indications

Symptomatic treatment of flatulence (excessive gas formation and bloating) associated with disorders of the gastrointestinal tract, including those caused by functional dyspepsia.

Pharmacological effect

Pharmacotherapeutic group: other drugs for the treatment of functional disorders of the gastrointestinal tract.

ATX code: A03AX13.
Pharmacological properties

Pharmacodynamics

Simethicone is a chemically inert polymer of methylsiloxane containing about 5% silicon dioxide.

Simethicone has antifoaming and antifoaming properties, significantly reduces the surface tension of purified water and model solutions of surfactants. The results of defoaming experiments demonstrated complete destruction of the foam within 3-6 seconds when adding a liquid suspension of simethicone at a concentration of 0.1 mg/ml. Below this threshold, complete destruction of the foam does not occur. As an antifoam agent, simethicone is also effective at a concentration of 0.1 mg/ml. This effect lasts for more than 24 hours.

The mechanism of action is based on the spread of silicone liquid over the surface of the foam film, as well as on a local change in surface tension in the contact area. Thus, rapid drainage of the liquid occurs, which contributes to the rupture of the film, as a result of which the released gas is able to be absorbed or excreted naturally.

Pharmacokinetics

Simethicone is a chemically inert substance that does not have physiological activity; it is not absorbed, passes through the digestive tract and is excreted unchanged.

Special instructions

If the medicine has become unusable or has expired, do not throw it into wastewater or throw it outside! Place the medication in a bag and place it in the trash. These measures will help protect the environment!

Effect of the drug on the ability to drive vehicles and machinery

The drug does not affect the ability to drive or engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

Active ingredient

Simethicone

Composition

For 1 capsule:

active ingredient:

simethicone – 120.00 mg;

excipients:

gelatin – 50.60 mg,

glycerol – 19.60 mg.

Pregnancy

There are no clinical data on the effects of simethicone when used during pregnancy.

Simethicone can be used during pregnancy only if the expected benefit of therapy for the mother outweighs the potential risk to the fetus, taking into account the fact that simethicone is not physiologically active and is not absorbed from the gastrointestinal tract. There is no data on the excretion of simethicone in breast milk.

If you are pregnant, or think you might be pregnant, or are planning a pregnancy, you should consult your doctor before using Motilegaz Forte.

Contraindications

Hypersensitivity to simethicone or other components of the drug, children under 18 years of age, intestinal obstruction.

Side Effects

The frequency of adverse reactions is given in the following gradation: very often (≥1/10); often (≥1/100, <1/10); uncommon (≥1/1000, <1/100); rare (≥1/10000, <1/1000); very rare (< 1/10000), including isolated reports of unspecified frequency (frequency cannot be calculated from available data).According to post-registration dataGastrointestinal disorders: Very rare: vomiting.Skin and subcutaneous tissue disorders: Very rare: angioedema, rash, allergic reactions to the components of the drug.If you have the side effects listed in the instructions, or they get worse, or you notice any other side effects not listed in the instructions, tell your doctor.

Storage conditions

Store at a temperature not exceeding 25 °C.
Keep out of the reach of children.

Shelf life

3 years.

Manufacturer

Catalent France Beinheim SA, France